做多
Possible Long Targets Set For SBBP
Strongbridge Biopharma Plc operates as a commercial-stage biopharmaceutical company, which focuses on the development and commercialization of therapies for rare diseases. Its pipeline is comprised of Keveyis, Macrilen, Recorlev, and Veldoreotide. The company was founded on May 26, 2015 and is headquartered in Lower Southampton, PA.
SHORT INTEREST
1.13M 08/15/19
Average Recommendation: BUY
Average Target Price: 13.71
P/E Current
7.53
P/E Ratio (with extraordinary items)
6.21
P/E Ratio (without extraordinary items)
6.51
SHORT INTEREST
1.13M 08/15/19
Average Recommendation: BUY
Average Target Price: 13.71
P/E Current
7.53
P/E Ratio (with extraordinary items)
6.21
P/E Ratio (without extraordinary items)
6.51
免責聲明
這些資訊和出版物並非旨在提供，也不構成TradingView提供或認可的任何形式的財務、投資、交易或其他類型的建議或推薦。請閱讀使用條款以了解更多資訊。
免責聲明
這些資訊和出版物並非旨在提供，也不構成TradingView提供或認可的任何形式的財務、投資、交易或其他類型的建議或推薦。請閱讀使用條款以了解更多資訊。